Protective effect of Bifidobacterium infantis CGMCC313-2 on ovalbumin-induced airway asthma and β-lactoglobulin-induced intestinal food allergy mouse models

To determine whether oral administration of CGMCC313-2 ( CGMCC313-2) inhibits allergen-induced airway inflammation and food allergies in a mouse model. Ovalbumin (OVA)-induced allergic asthma and β-lactoglobulin-induced food allergy mouse models were used in this study. Following oral administration...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2017-03, Vol.23 (12), p.2149-2158
Main Authors: Liu, Meng-Yun, Yang, Zhen-Yu, Dai, Wen-Kui, Huang, Jian-Qiong, Li, Yin-Hu, Zhang, Juan, Qiu, Chuang-Zhao, Wei, Chun, Zhou, Qian, Sun, Xin, Feng, Xin, Li, Dong-Fang, Wang, He-Ping, Zheng, Yue-Jie
Format: Article
Language:English
Subjects:
Allergens - chemistry
Animals
Asthma - chemically induced
Basic Study
Bifidobacterium longum subspecies infantis
Bronchoalveolar Lavage Fluid
Cytokines - blood
Disease Models, Animal
Food Hypersensitivity - prevention & control
Food Hypersensitivity - therapy
Immunoglobulin E - blood
Immunoglobulin G - blood
Inflammation
Interleukin-13 - blood
Interleukin-4 - blood
Intestines - immunology
Lactoglobulins - chemistry
Male
Mice
Mice, Inbred BALB C
Ovalbumin - chemistry
Probiotics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine whether oral administration of CGMCC313-2 ( CGMCC313-2) inhibits allergen-induced airway inflammation and food allergies in a mouse model. Ovalbumin (OVA)-induced allergic asthma and β-lactoglobulin-induced food allergy mouse models were used in this study. Following oral administration of CGMCC313-2 during or after allergen sensitization, histopathologic changes in the lung and intestine were evaluated by hematoxylin and eosin (HE) staining. In the allergic asthma mouse model, we evaluated the proportion of lung-infiltrating inflammatory cells. OVA-specific IgE and IgG1 levels in serum and cytokine levels in bronchoalveolar lavage fluid (BALF) were also assessed. In the food allergy mouse model, the levels of total IgE and cytokines in serum were measured. Oral administration of CGMCC313-2 during or after allergen sensitization suppressed allergic inflammation in lung and intestinal tissues, while the proportion of infiltrating inflammatory cells was significantly decreased in the BALF of allergic asthma mice. Moreover, CGMCC313-2 decreased the serum levels of total IgE in food allergy mice, and reductions in IgE and IgG1 were also observed in OVA-induced allergic asthma mice. The expression of interleukin-4 (IL-4) and IL-13 in both serum and BALF was suppressed following the administration of CGMCC313-2, while an effect on serum IL-10 levels was not observed. CGMCC313-2 inhibits the secretion of allergen-induced IgE, IL-4 and IL-13, and attenuates allergic inflammation.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v23.i12.2149